Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies.
- DOI
- 10.1016/j.ejca.2021.05.023
- Published
- 2021 Aug
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2021.05.023,
title = {Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies.},
author = {Geoerger B and Morland B and Jiménez I and Frappaz D and Pearson ADJ and Vassal G and Maeda P and Kincaide J and Mueller U and Schlief S and Teufel M and Ploeger BA and Cleton A and Agostinho AC and Marshall LV},
year = {2021},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2021.05.023},
url = {https://doi.org/10.1016/j.ejca.2021.05.023}
}RIS
TY - JOUR TI - Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies. AU - Geoerger B AU - Morland B AU - Jiménez I AU - Frappaz D AU - Pearson ADJ AU - Vassal G AU - Maeda P AU - Kincaide J AU - Mueller U AU - Schlief S AU - Teufel M AU - Ploeger BA AU - Cleton A AU - Agostinho AC AU - Marshall LV PY - 2021 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2021.05.023 UR - https://doi.org/10.1016/j.ejca.2021.05.023 ER -
APA
B, G., B, M., I, J., D, F., ADJ, P., G, V., P, M., J, K., U, M., S, S., M, T., BA, P., A, C., AC, A., & LV, M. (2021). Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2021.05.023
Source records
- pubmed · retrieved 2026-11-11T00:37:06.993Z
- europe-pmc · retrieved 2026-11-11T00:37:07.000Z
- hal · retrieved 2026-11-11T00:37:07.043Z